68 related articles for article (PubMed ID: 25890721)
1. Inhibition of indoleamine 2,3-dioxygenase activity accelerates skin wound healing.
Ito H; Ando T; Ogiso H; Arioka Y; Saito K; Seishima M
Biomaterials; 2015 Jun; 53():221-8. PubMed ID: 25890721
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive behavioral analysis of indoleamine 2,3-dioxygenase knockout mice.
Hirata N; Hattori S; Shoji H; Funakoshi H; Miyakawa T
Neuropsychopharmacol Rep; 2018 Sep; 38(3):133-144. PubMed ID: 30175526
[TBL] [Abstract][Full Text] [Related]
3. Disruption of microglia histone acetylation and protein pathways in mice exhibiting inflammation-associated depression-like symptoms.
Rodriguez-Zas SL; Wu C; Southey BR; O'Connor JC; Nixon SE; Garcia R; Zavala C; Lawson M; McCusker RH; Romanova EV; Sweedler JV; Kelley KW; Dantzer R
Psychoneuroendocrinology; 2018 Nov; 97():47-58. PubMed ID: 30005281
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia.
Lanis JM; Alexeev EE; Curtis VF; Kitzenberg DA; Kao DJ; Battista KD; Gerich ME; Glover LE; Kominsky DJ; Colgan SP
Mucosal Immunol; 2017 Sep; 10(5):1133-1144. PubMed ID: 28098246
[TBL] [Abstract][Full Text] [Related]
5. Interferon-Induced IDO1 Mediates Radiation Resistance and Is a Therapeutic Target in Colorectal Cancer.
Chen B; Alvarado DM; Iticovici M; Kau NS; Park H; Parikh PJ; Thotala D; Ciorba MA
Cancer Immunol Res; 2020 Apr; 8(4):451-464. PubMed ID: 32127391
[TBL] [Abstract][Full Text] [Related]
6. The tryptophan-metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression.
Nguyen DT; Kleczko EK; Dwivedi N; Monaghan MT; Gitomer BY; Chonchol MB; Clambey ET; Nemenoff RA; Klawitter J; Hopp K
JCI Insight; 2023 Jan; 8(1):. PubMed ID: 36422996
[TBL] [Abstract][Full Text] [Related]
7. Exogenous Tryptophan Promotes Cutaneous Wound Healing of Chronically Stressed Mice through Inhibition of TNF-α and IDO Activation.
Bandeira LG; Bortolot BS; Cecatto MJ; Monte-Alto-Costa A; Romana-Souza B
PLoS One; 2015; 10(6):e0128439. PubMed ID: 26057238
[TBL] [Abstract][Full Text] [Related]
8. Loss of Indoleamine-2,3-Dioxygenase-1 (IDO1) in Knockout Mice Does Not Affect the Development of Skin Lesions in the Imiquimod-Induced Mouse Model of Psoriasis.
Choudhary V; Ajebo E; Uaratanawong R; Spaulding SC; Hossack S; Chen X; Xu J; Choudhary M; Irsik DL; Isales CM; Bollag WB
Int J Tryptophan Res; 2022; 15():11786469221078191. PubMed ID: 35250276
[TBL] [Abstract][Full Text] [Related]
9. Indoleamine 2,3-dioxygenase 1 (ido1) is involved in the control of mouse caput epididymis immune environment.
Jrad-Lamine A; Henry-Berger J; Damon-Soubeyrand C; Saez F; Kocer A; Janny L; Pons-Rejraji H; Munn DH; Mellor AL; Gharbi N; Cadet R; Guiton R; Aitken RJ; Drevet JR
PLoS One; 2013; 8(6):e66494. PubMed ID: 23840489
[TBL] [Abstract][Full Text] [Related]
10. Trial watch: IDO inhibitors in cancer therapy.
Vacchelli E; Aranda F; Eggermont A; Sautès-Fridman C; Tartour E; Kennedy EP; Platten M; Zitvogel L; Kroemer G; Galluzzi L
Oncoimmunology; 2014 Nov; 3(10):e957994. PubMed ID: 25941578
[TBL] [Abstract][Full Text] [Related]
11. Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation.
Wang Q; Liu D; Song P; Zou MH
Front Biosci (Landmark Ed); 2015 Jun; 20(7):1116-43. PubMed ID: 25961549
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice.
Takamatsu M; Hirata A; Ohtaki H; Hoshi M; Ando T; Ito H; Hatano Y; Tomita H; Kuno T; Saito K; Seishima M; Hara A
Cancer Sci; 2015 Aug; 106(8):1008-15. PubMed ID: 26033215
[TBL] [Abstract][Full Text] [Related]
13. High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia.
Mabuchi R; Hara T; Matsumoto T; Shibata Y; Nakamura N; Nakamura H; Kitagawa J; Kanemura N; Goto N; Shimizu M; Ito H; Yamamoto Y; Saito K; Moriwaki H; Tsurumi H
Leuk Lymphoma; 2016; 57(1):92-8. PubMed ID: 25907424
[TBL] [Abstract][Full Text] [Related]
14. Expression and function analysis of indoleamine 2 and 3-dioxygenase in bladder urothelial carcinoma.
Yang C; Zhou Y; Zhang L; Jin C; Li M; Ye L
Int J Clin Exp Pathol; 2015; 8(2):1768-75. PubMed ID: 25973066
[TBL] [Abstract][Full Text] [Related]
15. Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus.
Lood C; Tydén H; Gullstrand B; Klint C; Wenglén C; Nielsen CT; Heegaard NH; Jönsen A; Kahn R; Bengtsson AA
PLoS One; 2015; 10(4):e0125109. PubMed ID: 25897671
[TBL] [Abstract][Full Text] [Related]
16. An Autocrine Cytokine/JAK/STAT-Signaling Induces Kynurenine Synthesis in Multidrug Resistant Human Cancer Cells.
Campia I; Buondonno I; Castella B; Rolando B; Kopecka J; Gazzano E; Ghigo D; Riganti C
PLoS One; 2015; 10(5):e0126159. PubMed ID: 25955018
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy.
Chinnadurai R; Copland IB; Ng S; Garcia M; Prasad M; Arafat D; Gibson G; Kugathasan S; Galipeau J
Mol Ther; 2015 Jul; 23(7):1248-1261. PubMed ID: 25899824
[TBL] [Abstract][Full Text] [Related]
18. Effects of indoleamine 2,3-dioxygenase inhibitor in non-Hodgkin lymphoma model mice.
Nakamura N; Hara T; Shimizu M; Mabuchi R; Nagano J; Ohno T; Kochi T; Kubota M; Shirakami Y; Goto N; Ito H; Saito K; Tanaka T; Moriwaki H; Tsurumi H
Int J Hematol; 2015 Sep; 102(3):327-34. PubMed ID: 26243621
[TBL] [Abstract][Full Text] [Related]
19. Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
Röhrig UF; Majjigapu SR; Vogel P; Zoete V; Michielin O
J Med Chem; 2015 Dec; 58(24):9421-37. PubMed ID: 25970480
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival.
Ferns DM; Kema IP; Buist MR; Nijman HW; Kenter GG; Jordanova ES
Oncoimmunology; 2015 Feb; 4(2):e981457. PubMed ID: 25949879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
